Literature DB >> 33475932

Surgery on giant meningiomas in very old patients entails frequent postoperative intracranial hemorrhages and atypical histopathology.

Roel H L Haeren1,2, Ilari Rautalin3, Christoph Schwartz3,4, Miikka Korja3, Mika Niemelä3.   

Abstract

PURPOSE: Surgical resection of intracranial meningiomas in patients that are 80 years old and older, i.e. very old patients, is increasingly considered. Meningiomas with a largest diameter of at least 5 cm-'giant meningiomas'-form a distinct entity, and their surgical resection is considered more difficult and prone to complications. Here, we evaluated functional outcome, morbidity and mortality, and the prognostic value of tumor size in very old patients who underwent resection of giant supratentorial meningiomas.
METHODS: We retrospectively reviewed clinical and radiological data, functional performance (Karnofsky Performance Score), histopathological diagnosis and complications of very old patients who underwent surgery of a supratentorial meningioma at the Helsinki University Hospital between 2010 and 2018.
RESULTS: We identified 76 very old patients, including 28 with a giant meningioma. Patients with a giant meningioma suffered from major complications more commonly than those with a non-giant meningioma (36% vs. 17%, p = 0.06), particularly from postoperative intracranial hemorrhages (ICH). At the 1-year follow-up, functional performance and mortality rate were comparable between patients with giant meningiomas and those with non-giant meningiomas. An exceptionally high rate of giant meningiomas were diagnosed as atypical meningiomas (WHO II) at an (11 out of 28 cases).
CONCLUSIONS: Giant meningioma surgery entails a high complication rate in frail, very old patients. The prevention of postoperative ICH in this specific patient group is of utmost importance. An atypical histopathology was notably frequent among very old patients with a giant meningioma, which should be taken into account when planning the surgical strategy.

Entities:  

Keywords:  Atypical; Complications; Elderly; Giant; Meningioma; Outcome; Surgery

Year:  2021        PMID: 33475932      PMCID: PMC7910228          DOI: 10.1007/s11060-020-03693-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  39 in total

1.  Management of incidental anterior skull base large and giant meningiomas in elderly patients.

Authors:  Yuqian Li; Dan Lu; Dayun Feng; Hongyu Cheng; Qian Huang; Haikang Zhao; Peng Chen; Huaizhou Qin; Qing Cai
Journal:  J Neurooncol       Date:  2020-06-11       Impact factor: 4.130

2.  Meningioma surgery in the very old-validating prognostic scoring systems.

Authors:  Ane Konglund; Siril G Rogne; Eirik Helseth; Torstein R Meling
Journal:  Acta Neurochir (Wien)       Date:  2013-09-13       Impact factor: 2.216

3.  Preoperative identification of neurosurgery patients with a high risk of in-hospital complications: a prospective cohort of 418 consecutive elective craniotomy patients.

Authors:  Elina Reponen; Miikka Korja; Tomi Niemi; Marja Silvasti-Lundell; Juha Hernesniemi; Hanna Tuominen
Journal:  J Neurosurg       Date:  2015-05-01       Impact factor: 5.115

4.  Differentiating meningioma grade by imaging features on magnetic resonance imaging.

Authors:  Andrew T Hale; Li Wang; Megan K Strother; Lola B Chambless
Journal:  J Clin Neurosci       Date:  2017-11-22       Impact factor: 1.961

5.  Giant olfactory groove meningiomas: extent of frontal lobes damage and long-term outcome after the pterional approach.

Authors:  Francesco Tomasello; Filippo Flavio Angileri; Giovanni Grasso; Francesca Granata; Francesco Saverio De Ponte; Concetta Alafaci
Journal:  World Neurosurg       Date:  2011 Sep-Oct       Impact factor: 2.104

Review 6.  Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.

Authors:  Leland Rogers; Igor Barani; Marc Chamberlain; Thomas J Kaley; Michael McDermott; Jeffrey Raizer; David Schiff; Damien C Weber; Patrick Y Wen; Michael A Vogelbaum
Journal:  J Neurosurg       Date:  2015-01       Impact factor: 5.115

7.  Symptomatic peritumoral edema is associated with surgical outcome: a consecutive series of 72 supratentorial meningioma patients ≥ 80 years of age.

Authors:  Christoph Schwartz; Ilari Rautalin; Mika Niemelä; Miikka Korja
Journal:  J Neurooncol       Date:  2020-04-22       Impact factor: 4.130

8.  Poor awareness of IADL deficits is associated with reduced regional brain volume in older adults with cognitive impairment.

Authors:  Kayla A Steward; Richard Kennedy; Guray Erus; Ilya M Nasrallah; Virginia G Wadley
Journal:  Neuropsychologia       Date:  2019-05-04       Impact factor: 3.139

9.  Effects of intracranial meningioma location, size, and surgery on neurocognitive functions: a 3-year prospective study.

Authors:  Evangelia Liouta; Christos Koutsarnakis; Faidon Liakos; George Stranjalis
Journal:  J Neurosurg       Date:  2015-12-04       Impact factor: 5.115

Review 10.  Cognitive functioning in meningioma patients: a systematic review.

Authors:  Ikram Meskal; Karin Gehring; Geert-Jan M Rutten; Margriet M Sitskoorn
Journal:  J Neurooncol       Date:  2016-04-05       Impact factor: 4.130

View more
  3 in total

1.  Are the clinical manifestations of CT scan and location associated with World Health Organization histopathological grades of meningioma?: A retrospective study.

Authors:  Razieh Behzadmehr; Rezvaneh Behzadmehr
Journal:  Ann Med Surg (Lond)       Date:  2021-04-30

2.  The Surgical Risk Factors of Giant Intracranial Meningiomas: A Multi-Centric Retrospective Analysis of Large Case Serie.

Authors:  Daniele Armocida; Antonia Catapano; Mauro Palmieri; Umberto Aldo Arcidiacono; Alessandro Pesce; Fabio Cofano; Veronica Picotti; Maurizio Salvati; Diego Garbossa; Giancarlo D'Andrea; Antonio Santoro; Alessandro Frati
Journal:  Brain Sci       Date:  2022-06-22

3.  Mortality of surgically treated 80-year-old or older intracranial meningioma patients in comparison to matched general population.

Authors:  Ilari Rautalin; Christoph Schwartz; Mika Niemelä; Miikka Korja
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.